Evaluation of PIVKA-II efficiency in the diagnosis of early hepatocellular carcinoma

被引：0
|
作者：
Saitta, Carlo [2 ]
Raffa, Giuseppina [2 ]
di Tocco, Francesca Casuscelli [2 ]
Brancatelli, Santa [2 ]
Alibrandi, Angela [3 ]
Raimondo, Giovanni [2 ]
Pollicino, Teresa [1 ]
机构：
[1] Univ Hosp Messina, Pediat Gynecol Microbiol & Biomed Sci, Messina, Italy
[2] Univ Hosp Messina, Clin & Expt Med, Messina, Italy
[3] Univ Messina, Messina, Italy
来源：
HEPATOLOGY | 2015年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1898
引用
收藏
页码：1134A / 1134A
页数：1
相关论文
共 50 条
  • [11] Diagnostic performance of PIVKA-II in patients with hepatocellular carcinoma
    Guarneri, Valeria
    Loggi, Elisabetta
    Serra, Carla
    Vukotic, Ranka
    Cevenini, Monica
    Cursaro, Carmela
    Scuteri, Alessandra
    Vitale, Giovanni
    Margotti, Marzia
    Galli, Silvia
    Galli, Claudio
    Andreone, Pietro
    JOURNAL OF HEPATOLOGY, 2020, 73 : S631 - S632
  • [12] Clinical value of serum AFP and PIVKA-II for diagnosis, treatment and prognosis of hepatocellular carcinoma
    Jin, Yujiao
    Xu, Aifang
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2024,
  • [13] Diagnostic Performance of PIVKA-II in Italian Patients with Hepatocellular Carcinoma
    Guarneri, Valeria
    Loggi, Elisabetta
    Ramacieri, Giuseppe
    Serra, Carla
    Vukotic, Ranka
    Vitale, Giovanni
    Scuteri, Alessandra
    Cursaro, Carmela
    Margotti, Marzia
    Galli, Silvia
    Caracausi, Maria
    Brodosi, Lucia
    Gabrielli, Filippo
    Andreone, Pietro
    CANCERS, 2025, 17 (02)
  • [14] CLINICOPATHOLOGICAL SIGNIFICANCE OF PIVKA-II AND AFP IN HEPATOCELLULAR-CARCINOMA
    NAKAGAWA, T
    SEKI, T
    SHIRO, T
    WAKABAYASHI, M
    ITOH, T
    IMAMURA, M
    TAMAI, T
    SHIOZAKI, Y
    INOUE, K
    OKAMURA, A
    HEPATOLOGY, 1995, 22 (04) : 322 - 322
  • [15] Clinical value of serum AFP and PIVKA-II for diagnosis, treatment and prognosis of hepatocellular carcinoma
    Tian, Shan
    Chen, Yongyi
    Zhang, Yimin
    Xu, Xiaohong
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2023, 37 (01)
  • [16] The role of PIVKA-II in hepatocellular carcinoma surveillance in an Asian population
    Ng, Wai-Yoong
    Lim, Daniel Yan-Zheng
    Tan, Si-Yu
    Chang, Jason Pik-Eu
    Krishnamoorthy, Thinesh Lee
    Lim, Chee-Hooi
    Tan, Damien Meng-Yew
    Ekstrom, Victoria Sze-Min
    Goh, George Boon-Bee
    Cheah, Mark Chang-Chuen
    Kumar, Rajneesh
    Yeo, Chin-Pin
    Tan, Chee-Kiat
    ANNALS ACADEMY OF MEDICINE SINGAPORE, 2023, 52 (02) : 108 - 110
  • [17] The utility of PIVKA-II as a biomarker for treatment response in hepatocellular carcinoma
    Patricia Varquez, Charmaine
    Eternity Labio, Madalinee
    GUT, 2023, 72 (SUPPL_1) : A173 - A173
  • [18] EVALUATION OF PIVKA-II AS A PREDICTOR MARKER FOR PORTAL VEIN THROMBOSIS IN HEPATOCELLULAR CARCINOMA PATIENTS
    Ayoub, M.
    Hemida, K.
    Kamai, W.
    Riad, G.
    Adele, N.
    Ayoub, D.
    HAEMATOLOGICA, 2013, 98 : 209 - 209
  • [19] Histological study of PIVKA-II expression in hepatocellular carcinoma and adenomatous hyperplasia
    Miskad, UA
    Yano, Y
    Nakaji, M
    Kishi, S
    Itoh, H
    Kim, SR
    Ku, YS
    Kuroda, Y
    Hayashi, Y
    PATHOLOGY INTERNATIONAL, 2001, 51 (12) : 916 - 922
  • [20] PIVKA-II as a Potential New Biomarker for Hepatocellular Carcinoma - A Pilot Study
    Svobodova, Sarka
    Karlikova, Marie
    Topolcan, Ondrej
    Pecen, Ladislav
    Pestova, Martina
    Kott, Otto
    Treska, Vladislav
    Slouka, David
    Kucera, Radek
    IN VIVO, 2018, 32 (06): : 1551 - 1554
12345